These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7437205)

  • 21. Clinical studies of Norpace. Summarizing remarks.
    Fowler NO
    Angiology; 1975 Jan; 26(1 Pt 2):154-5. PubMed ID: 1090216
    [No Abstract]   [Full Text] [Related]  

  • 22. [Use of intravenous disopyramide in 126 cases of cardiac rhythm disorders (author's transl)].
    Ducloux G; Faivre G; Perrin A; Raynaud R; Canicave JC; Fauchier JP; Groussin P; Loire R; Saulnier JP
    Ann Cardiol Angeiol (Paris); 1978; 27(4):297-302. PubMed ID: 80150
    [No Abstract]   [Full Text] [Related]  

  • 23. [Treatment of disturbances of cardiac rhythm using intravenous disopyramide].
    Lisin N; Andriange M; Vandenbosch R; Carlier J
    Rev Med Liege; 1974 May; 29(9):256-64. PubMed ID: 4134825
    [No Abstract]   [Full Text] [Related]  

  • 24. The use of intravenous disopyramide for the conversion of supraventricular tachyarrhythmias.
    Stewart DE; Ikram H
    N Z Med J; 1984 Mar; 97(751):148-50. PubMed ID: 6584758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atypical ventricular tachycardia (torsade de pointes) induced by amiodarone: arrhythmia previously induced by quinidine and disopyramide.
    Keren A; Tzivoni D; Gottlieb S; Benhorin J; Stern S
    Chest; 1982 Mar; 81(3):384-6. PubMed ID: 7056119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selective blockade of retrograde fast pathway by intravenous disopyramide in paroxysmal supraventricular tachycardia mediated by dual atrioventricular nodal pathways.
    Sethi KK; Jaishankar S; Khalilullah M; Gupta MP
    Br Heart J; 1983 Jun; 49(6):532-43. PubMed ID: 6849716
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The pharmacology of Norpace.
    Dean RR
    Angiology; 1975 Jan; 26(1 Pt 2):67-84. PubMed ID: 1115403
    [No Abstract]   [Full Text] [Related]  

  • 28. Disopyramide induced atypical ventricular tachycardia.
    Chia BL
    Aust N Z J Med; 1980 Dec; 10(6):665-8. PubMed ID: 6938189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of amiodarone and disopyramide in the control of paroxysmal atrial fibrillation and atrial flutter (interim report).
    Martin A; Benbow LJ; Leach C; Bailey RJ
    Br J Clin Pract Suppl; 1986 Apr; 44():52-60. PubMed ID: 3089263
    [No Abstract]   [Full Text] [Related]  

  • 30. Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias.
    Boudonas G; Lefkos N; Efthymiadis AP; Styliadis IG; Tsapas G
    Acta Cardiol; 1995; 50(2):125-34. PubMed ID: 7610735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adverse reaction to disopyramide.
    Dibble JB; Webster NR
    Postgrad Med J; 1979 Sep; 55(646):570-2. PubMed ID: 514940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Can 1/1 atrial flutter be foreseen by class I anti-arrhythmics?].
    Brembilla-Perrot B; Terrier de la Chaise A; Jacquemin L; Beurrier D; Houplon P; Louis P; Danchin N
    Arch Mal Coeur Vaiss; 1997 Jul; 90(7):961-6. PubMed ID: 9339257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Ventricular fibrillation during disopyramide treatment].
    Edhag O; Forssell G; Schenck-Gustafsson K
    Lakartidningen; 1981 Oct; 78(41):3597-600. PubMed ID: 7321703
    [No Abstract]   [Full Text] [Related]  

  • 34. Disopyramide-induced QT prolongation and ventricular tachyarrhythmias.
    Riccioni N; Castiglioni M; Bartolomei C
    Am Heart J; 1983 May; 105(5):870-1. PubMed ID: 6846134
    [No Abstract]   [Full Text] [Related]  

  • 35. Atrial flutter in Wolff-Parkinson-White syndrome responding to intravenous disopyramide.
    Chia BL; Choo MH; Tan AT; Ee B
    Chest; 1984 Jun; 85(6):820-1. PubMed ID: 6723395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potentially dangerous effect of disopyramide on atrioventricular conduction in a patient on digitalis.
    Lara M; Oakley GD; Rowbotham D
    Br Med J; 1980 Jul; 281(6234):198. PubMed ID: 7407521
    [No Abstract]   [Full Text] [Related]  

  • 37. [Proarrhythmic effect of propafenone in patients with atrial fibrillation and atrial flutter].
    Jastrzebski M
    Kardiol Pol; 2008 Nov; 66(11):1221-4; discussion 1225. PubMed ID: 19105102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoglycemic effect of disopyramide in a case of diabetes mellitus under insulin treatment.
    Taketa K; Yamamoto Y
    Acta Med Okayama; 1980 Sep; 34(4):289-92. PubMed ID: 6452032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Atrial flutter with 1:1 AV conduction during intravenous flecainide treatment].
    Heldal M; Orning OM
    Tidsskr Nor Laegeforen; 1989 Aug; 109(23):2309-10. PubMed ID: 2505404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous sotalol for the treatment of atrial fibrillation and flutter after cardiopulmonary bypass. Comparison with disopyramide and digoxin in a randomised trial.
    Campbell TJ; Gavaghan TP; Morgan JJ
    Br Heart J; 1985 Jul; 54(1):86-90. PubMed ID: 3893488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.